Pharmafile Logo

OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward

October 20, 2020 |  

The COVID-19 pandemic has permanently changed how medical education in the healthcare industry is conducted. Over the last few months, all conferences, medical education and field force deliverables have either been cancelled or re-organised to be virtual in a short space of time. We fully expect that this isn’t in the short term and reflects the future to come. These changes were unprecedented but reshaping the way we carry out activities has unveiled a new strength and opportunity to add value through a multi channel approach.

OPEN Health, much like the rest of the industry quickly adapted our activities at the start of COVID-19. We’re extremely proud of all our teams for delivering clinically relevant, fresh and purposeful virtual solutions for all our clients. Over the last few months, our teams have worked incredibly hard to deliver over 250 fantastic virtual projects for our clients. See below an indication of some of the activities we’ve worked on:

Pink divider
- PMLiVE

As we head towards the end of the year, we will be looking back and reflecting at our virtual activities from 2020, gathering feedback from clients and HCPs on the most impactful activities and will be providing our recommendations for 2021. Keep an eye out for future blogs, webinars and more covering these topics.

Pink divider

To learn more about our virtual capabilities, please contact:

Louise Carrington, Client Partnerships Director

Email: LouiseCarrington@openhealthgroup.com

Mobile: +44 (0)7468 714548

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

How digital health is changing the relationship between patients and health providers | OPEN Health

The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes